Gil Addo

Gil Addo is CEO and Co-founder of RubiconMD, a wholly-owned subsidiary of Oak Street Health. RubiconMD is the leading multi-specialty care platform, empowering over 8,000 primary care clinicians with access to virtual specialist support to improve patient care. Founded in 2013, RubiconMD serves primary care clinicians across 37 states. The Huffington Post named RubiconMD one of the “Five Companies Defining the Future of Healthcare” and, in 2020, AllianceBernstein ranked RubiconMD number 12 on its list of the top 25 private companies disrupting healthcare. The company raised over $40 million in capital from top tier investment firms and in 2021 was acquired by Oak Street Health for $190 million. Prior to founding RubiconMD, Gil was a Consultant at Putnam Associates, a pharma strategy consultancy, where he designed payer and market access strategies for fortune 500 clients. He previously held strategy and business development roles at Xerox, Cubist (acquired by Merck), and two early stage healthcare ventures. Gil has appeared in Inc, Forbes, CNBC, Fortune and Entrepreneur Magazine. He’s been named one of Forbes’ “30 Under 30” in healthcare, Crains New York Business 40 Under 40 and Business Insider’s 30 under 40 in healthcare. In 2020, Crains New York named Gil to its list of the Most Notable in Health Care and in 2017 he received their Heritage Healthcare Innovator of the Year award. He holds a BS in Economics and Biomedical Engineering from Yale and an MBA from Harvard.